The Vanderbilt Vaccine Research Program is one of only eight Vaccine Treatment and Evaluation Units (VTEUs) in the U.S. to receive a new contract to continue evaluating innovative vaccines for malaria, pandemic flu, and other infections including TB over the next seven years. The unit may work on phase 1, 2, 3 and 4 clinical trials to evaluate vaccines, therapeutics and diagnostics for safety and effectiveness in a domestic or international setting. VTEUs are on the forefront of research in fighting and preventing infectious diseases.
|Buddy Creech [Email]
Pediatric Infectious Disease
|Global Health Topics||
Infectious Diseases, Neglected Tropical Diseases, Vaccines
Flexible, depending on the individual's interests and needs
The program is affiliated with Vanderbilt.
The program does not have a language requirement.